X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1527) 1527
humans (1478) 1478
mutation (962) 962
proto-oncogene proteins b-raf - genetics (911) 911
cancer (841) 841
oncology (788) 788
female (777) 777
male (760) 760
braf (729) 729
braf mutation (692) 692
braf v600e mutation (683) 683
middle aged (649) 649
adult (567) 567
melanoma (532) 532
aged (473) 473
thyroid neoplasms - genetics (469) 469
pathology (459) 459
carcinoma (440) 440
prognosis (410) 410
thyroid cancer (405) 405
genetic aspects (388) 388
thyroid neoplasms - pathology (388) 388
tumors (381) 381
gene mutations (360) 360
braf v600e (358) 358
vemurafenib (333) 333
endocrinology & metabolism (317) 317
v600e mutation (312) 312
immunohistochemistry (304) 304
diagnosis (280) 280
metastasis (261) 261
thyroid cancer, papillary (250) 250
expression (247) 247
surgery (234) 234
association (230) 230
metastatic melanoma (229) 229
papillary thyroid carcinoma (228) 228
analysis (224) 224
neoplasms (217) 217
aged, 80 and over (215) 215
young adult (215) 215
cell biology (213) 213
melanoma - genetics (213) 213
proto-oncogene proteins b-raf - metabolism (211) 211
research (206) 206
survival (202) 202
adolescent (201) 201
animals (200) 200
dna mutational analysis (198) 198
v600e (197) 197
carcinoma, papillary (195) 195
article (188) 188
thyroid (182) 182
carcinoma - genetics (181) 181
biomarkers, tumor - genetics (180) 180
care and treatment (178) 178
endocrine system diseases (177) 177
carcinoma, papillary - genetics (176) 176
health aspects (174) 174
b-raf (172) 172
retrospective studies (168) 168
kinases (166) 166
proto-oncogene proteins b-raf - antagonists & inhibitors (165) 165
cell line, tumor (164) 164
thyroid neoplasms - diagnosis (158) 158
mutations (157) 157
colorectal cancer (156) 156
abridged index medicus (153) 153
mutation - genetics (151) 151
medicine & public health (145) 145
gene (144) 144
nodules (143) 143
activation (138) 138
melanoma - pathology (138) 138
neoplasm staging (136) 136
carcinoma - pathology (134) 134
carcinoma, papillary - pathology (134) 134
microsatellite instability (133) 133
thyroid neoplasms - metabolism (133) 133
melanoma - drug therapy (132) 132
papillary thyroid cancer (131) 131
recurrence (130) 130
digestive system diseases (128) 128
management (127) 127
pathway (126) 126
patients (124) 124
antineoplastic agents - therapeutic use (120) 120
development and progression (117) 117
high prevalence (117) 117
risk factors (117) 117
medicine, research & experimental (115) 115
treatment outcome (113) 113
colorectal neoplasms - genetics (112) 112
resistance (112) 112
child (111) 111
polymerase chain reaction (111) 111
thyroid neoplasms - surgery (111) 111
cells (110) 110
fine-needle-aspiration (110) 110
dabrafenib (109) 109
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2343) 2343
French (17) 17
German (14) 14
Spanish (6) 6
Korean (5) 5
Chinese (2) 2
Polish (2) 2
Russian (2) 2
Czech (1) 1
Hungarian (1) 1
Japanese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 14, pp. 1457 - 1457
Journal Article
by Kim, TH and Park, YJ and Lim, JA and Ahn, HY and Lee, EK and Lee, YJ and Kim, KW and Hahn, SK and Youn, YK and Kim, KH and Cho, BY and Park, DJ
CANCER, ISSN 0008-543X, 04/2012, Volume 118, Issue 7, pp. 1764 - 1773
BACKGROUND: The effects of the BRAF(V600E) mutation on prognostic factors and poor clinical outcomes in papillary thyroid cancer (PTC) have not been fully... 
POPULATION | METAANALYSIS | meta-analysis | BRAF V600E MUTATION | BRAF | thyroid cancer | V600E | papillary | ONCOLOGY | HIGH-RISK | GROWTH-FACTOR | papillary thyroid carcinoma | HIGH PREVALENCE | CARCINOMA | PROGRESSION | CLINICOPATHOLOGICAL FEATURES | GENETIC ALTERATIONS
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 08/2015, Volume 33, Issue 22
Journal Article
Journal Article
Clinical Oncology, ISSN 0936-6555, 06/2019, Volume 31, Issue 6, pp. 337 - 340
Journal Article
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, ISSN 0021-972X, 07/2012, Volume 97, Issue 7, pp. 2333 - 2340
Context: BRAF(V600E) is considered a negative prognostic marker in papillary thyroid carcinoma (PTC), but unexplained conflicting results are present in the... 
CELLS | POPULATION | B-RAF(V600E) | METAANALYSIS | NEEDLE-ASPIRATION BIOPSY | ENDOCRINOLOGY & METABOLISM | BRAF V600E MUTATION | RET/PTC REARRANGEMENTS | CANCER | EXPRESSION | CLINICOPATHOLOGICAL FEATURES
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 10/2014, Volume 20, Issue 19, pp. 4994 - 5000
On August 17, 2011, the U. S. Food and Drug Administration (FDA) approved vemurafenib tablets (Zelboraf, Hoffmann-LaRoche Inc.) for the treatment of patients... 
SURVIVAL | V600E | INHIBITION | ONCOLOGY | PATHWAY | RAF | RESISTANCE | BRAF | FUTURE
Journal Article
MALAYSIAN JOURNAL OF PATHOLOGY, ISSN 0126-8635, 04/2017, Volume 39, Issue 1, pp. 95 - 96
Journal Article
CANCER, ISSN 0008-543X, 08/2013, Volume 119, Issue 15, pp. 2765 - 2770
BACKGROUND A point mutation (V600E) in the BRAF oncogene is a prognostic biomarker and may predict for nonresponse to anti-EGFR antibody therapy in patients... 
SURVIVAL | microsatellite instability | colon cancer | PREDICTIVE-VALUE | METASTATIC COLORECTAL-CANCER | STAGE-II | CETUXIMAB | BRAF(V600E) mutation | MELANOMA | ONCOLOGY | BRAF MUTATION | KRAS | immunohistochemistry | BRAF(V600E) protein | MISMATCH-REPAIR STATUS
Journal Article